GD
GDTTY
Guangdong Dtech Technology Co., Ltd.—
Price
Daily candles with volume.
No data for this timeframe.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 24, 2026 Clinical trial readout
Results Pending: SHR-1819 (Phase 3) — Completed 59d ago
Trial: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatit
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 26, 2026
Clinical Trial
🔒 Fresh data, subscribers only
Oct 24, 2026
Trial readout
Results Pending: SHR-1819 (Phase 3) — Completed 59d ago
Trial: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis Sponsor: Guangdong Hengrui Pharmaceutical…
Sep 8, 2026
Trial readout
Results Pending: SHR-1819 (Phase 3) — Completed 13d ago
Trial: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis Sponsor: Guangdong Hengrui Pharmaceutical…
Sep 8, 2026
Trial readout
Results Pending: SHR-1819 (Phase 3) — Completed 13d ago
Trial: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis Sponsor: Guangdong Hengrui Pharmaceutical…
Sep 3, 2026
Trial readout
Results Pending: SHR-1819 (Phase 3) — Completed 8d ago
Trial: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis Sponsor: Guangdong Hengrui Pharmaceutical…